This memo outlines policies adopted by Montifiore Health System to continue patient access to buprenorphine treatment during the COVID-19 pandemic. It includes information about the roles of prescribers, treatment coordinators, and community health workers in serving patients during the crisis, the adoption of telemedicine for all patient visits, and the suspension of urine drug testing requirements. Part of a collection of COVID-19 materials prepared by Montifiore Health System for clinicians and patients.
Funding Source: Montifiore Health Systems
Montefiore Buprenorphine Treatment Network COVID-19 Response Memo
A copy of the policies adopted by Montifiore Health System to continue patient access to buprenorphine treatment during the COVID-19 pandemic